Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma
Clinical trial NCT01689870 · WITHDRAWN
Trial details
- NCT number
- NCT01689870
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.